This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tessmer, U.
Right arrow Articles by Kräusslich, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tessmer, U.
Right arrow Articles by Kräusslich, H.-G.

 Previous Article  |  Next Article 

J Virol, April 1998, p. 3459-3463, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Cleavage of Human Immunodeficiency Virus Type 1 Proteinase from the N-Terminally Adjacent p6* Protein Is Essential for Efficient Gag Polyprotein Processing and Viral Infectivity

Uwe Tessmer and Hans-Georg Kräusslich*

Heinrich-Pette-Institut, D-20251 Hamburg, Germany

Received 5 September 1997/Accepted 19 December 1997

Maturation of infectious human immunodeficiency virus (HIV) particles requires proteolytic cleavage of the structural polyproteins by the viral proteinase (PR), which is itself encoded as part of the Gag-Pol polyprotein. Expression of truncated PR-containing sequences in heterologous systems has mostly led to the autocatalytic release of an 11-kDa species of PR which is capable of processing all known cleavage sites on the viral precursor proteins. Relatively little is known about cleavages within the nascent virus particle, on the other hand, and controversial results concerning the active PR species inside the virion and the relative activities of extended PR species have been reported. Here, we report that HIV type 1 (HIV-1) particles of four different strains obtained from different cell lines contain an 11-kDa PR, with no extended PR proteins detectable. Furthermore, mutation of the N-terminal PR cleavage site leading to production of an N-terminally extended 17-kDa PR species caused a severe defect in Gag polyprotein processing and a complete loss of viral infectivity. We conclude that N-terminal release of PR from the HIV-1 polyprotein is essential for viral replication and suggest that extended versions of PR may have a transient function in the proteolytic cascade.

* Corresponding author. Mailing address: Heinrich-Pette-Institut, Martinistr. 52, D-20251 Hamburg, Germany. Phone: 49 40 48051-241. Fax: 49 40 48051-184. E-mail: hgk{at}hpi.uni-hamburg.de.




This article has been cited by other articles:

  • Huang, L., Sayer, J. M., Swinford, M., Louis, J. M., Chen, C. (2009). Modulation of Human Immunodeficiency Virus Type 1 Protease Autoprocessing by Charge Properties of Surface Residue 69. J. Virol. 83: 7789-7793 [Abstract] [Full Text]  
  • Leiherer, A., Ludwig, C., Wagner, R. (2009). Uncoupling Human Immunodeficiency Virus Type 1 gag and pol Reading Frames: Role of the Transframe Protein p6* in Viral Replication. J. Virol. 83: 7210-7220 [Abstract] [Full Text]  
  • Ludwig, C., Leiherer, A., Wagner, R. (2008). Importance of Protease Cleavage Sites within and Flanking Human Immunodeficiency Virus Type 1 Transframe Protein p6* for Spatiotemporal Regulation of Protease Activation. J. Virol. 82: 4573-4584 [Abstract] [Full Text]  
  • Chiu, H.-C., Wang, F.-D., Chen, Y.-M. A., Wang, C.-T. (2006). Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing. J. Gen. Virol. 87: 2041-2046 [Abstract] [Full Text]  
  • Mo, H., King, M. S., King, K., Molla, A., Brun, S., Kempf, D. J. (2005). Selection of Resistance in Protease Inhibitor-Experienced, Human Immunodeficiency Virus Type 1-Infected Subjects Failing Lopinavir- and Ritonavir-Based Therapy: Mutation Patterns and Baseline Correlates. J. Virol. 79: 3329-3338 [Abstract] [Full Text]  
  • Mo, H., Lu, L., Pithawalla, R., Kempf, D. J., Molla, A. (2004). Complementation in Cells Cotransfected with a Mixture of Wild-Type and Mutant Human Immunodeficiency Virus (HIV) Influences the Replication Capacities and Phenotypes of Mutant Variants in a Single-Cycle HIV Resistance Assay. J. Clin. Microbiol. 42: 4169-4174 [Abstract] [Full Text]  
  • Myint, L., Matsuda, M., Matsuda, Z., Yokomaku, Y., Chiba, T., Okano, A., Yamada, K., Sugiura, W. (2004). Gag Non-Cleavage Site Mutations Contribute to Full Recovery of Viral Fitness in Protease Inhibitor-Resistant Human Immunodeficiency Virus Type 1. Antimicrob. Agents Chemother. 48: 444-452 [Abstract] [Full Text]  
  • Ishima, R., Torchia, D. A., Lynch, S. M., Gronenborn, A. M., Louis, J. M. (2003). Solution Structure of the Mature HIV-1 Protease Monomer: INSIGHT INTO THE TERTIARY FOLD AND STABILITY OF A PRECURSOR. J. Biol. Chem. 278: 43311-43319 [Abstract] [Full Text]  
  • de Oliveira, T., Engelbrecht, S., Janse van Rensburg, E., Gordon, M., Bishop, K., zur Megede, J., Barnett, S. W., Cassol, S. (2003). Variability at Human Immunodeficiency Virus Type 1 Subtype C Protease Cleavage Sites: an Indication of Viral Fitness?. J. Virol. 77: 9422-9430 [Abstract] [Full Text]  
  • Pettit, S. C., Gulnik, S., Everitt, L., Kaplan, A. H. (2002). The Dimer Interfaces of Protease and Extra-Protease Domains Influence the Activation of Protease and the Specificity of GagPol Cleavage. J. Virol. 77: 366-374 [Abstract] [Full Text]  
  • Hill, M. K., Shehu-Xhilaga, M., Crowe, S. M., Mak, J. (2002). Proline Residues within Spacer Peptide p1 Are Important for Human Immunodeficiency Virus Type 1 Infectivity, Protein Processing, and Genomic RNA Dimer Stability. J. Virol. 76: 11245-11253 [Abstract] [Full Text]  
  • Campbell, S., Oshima, M., Mirro, J., Nagashima, K., Rein, A. (2002). Reversal by Dithiothreitol Treatment of the Block in Murine Leukemia Virus Maturation Induced by Disulfide Cross-Linking. J. Virol. 76: 10050-10055 [Abstract] [Full Text]  
  • Yusa, K., Song, W., Bartelmann, M., Harada, S. (2002). Construction of a Human Immunodeficiency Virus Type 1 (HIV-1) Library Containing Random Combinations of Amino Acid Substitutions in the HIV-1 Protease due to Resistance by Protease Inhibitors. J. Virol. 76: 3031-3037 [Abstract] [Full Text]  
  • Chen, N., Morag, A., Almog, N., Blumenzweig, I., Dreazin, O., Kotler, M. (2001). Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1. J. Gen. Virol. 82: 581-590 [Abstract] [Full Text]  
  • Wang, C.-T., Chou, Y.-C., Chiang, C.-C. (2000). Assembly and Processing of Human Immunodeficiency Virus Gag Mutants Containing a Partial Replacement of the Matrix Domain by the Viral Protease Domain. J. Virol. 74: 3418-3422 [Abstract] [Full Text]  
  • Louis, J. M., Wondrak, E. M., Kimmel, A. R., Wingfield, P. T., Nashed, N. T. (1999). Proteolytic Processing of HIV-1 Protease Precursor, Kinetics and Mechanism. J. Biol. Chem. 274: 23437-23442 [Abstract] [Full Text]  
  • Paulus, C., Hellebrand, S., Tessmer, U., Wolf, H., Krausslich, H.-G., Wagner, R. (1999). Competitive Inhibition of Human Immunodeficiency Virus Type-1 Protease by the Gag-Pol Transframe Protein. J. Biol. Chem. 274: 21539-21543 [Abstract] [Full Text]  
  • Louis, J. M., Oroszlan, S., Tozser, J. (1999). Stabilization from Autoproteolysis and Kinetic Characterization of the Human T-cell Leukemia Virus Type 1 Proteinase. J. Biol. Chem. 274: 6660-6666 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»